Phylogenomic and genomic analysis reveals unique and shared genetic signatures of Mycobacterium kansasii complex species
Authors:
- Edson MachadoEMEdson Machado
- Sidra VasconcellosSVSidra Vasconcellos
- Lia GomesLGLia Gomes
- Marcos CatanhoMCMarcos Catanho
- Jesus RamosJRJesus Ramos
- Luciana de CarvalhoLCLuciana de Carvalho
- Telma GoldenbergTGTelma Goldenberg
- Paulo RednerPRPaulo Redner
- Paulo CaldasPCPaulo Caldas
- Carlos CamposCCCarlos Campos
- Margareth DalcolmoMargareth Dalcolmo
- Maria Cristina LourençoMLMaria Cristina Lourenço
Open Access
- 17 July 2024
- journal article
- research article
- Published by Microbiology Society in Microbial Genomics
- Vol. 10 (7) , 001266
Abstract
Species belonging to the Mycobacterium kansasii complex (MKC) are frequently isolated from humans and the environment and can cause serious diseases. The most common MKC infections are caused by the species M. kansasii (sensu stricto), leading to tuberculosis-like disease. However, a broad spectrum of virulence, antimicrobial resistance and pathogenicity of these non-tuberculous mycobacteria (NTM) are observed across the MKC. Many genomic aspects of the MKC that relate to these broad phenotypes are not well elucidated. Here, we performed genomic analyses from a collection of 665 MKC strains, isolated from environmental, animal and human sources. We inferred the MKC pangenome, mobilome, resistome, virulome and defence systems and show that the MKC species harbours unique and shared genomic signatures. High frequency of presence of prophages and different types of defence systems were observed. We found that the M. kansasii species splits into four lineages, of which three are lowly represented and mainly in Brazil, while one lineage is dominant and globally spread. Moreover, we show that four sub-lineages of this most distributed M. kansasii lineage emerged during the twentieth century. Further analysis of the M. kansasii genomes revealed almost 300 regions of difference contributing to genomic diversity, as well as fixed mutations that may explain the M. kansasii’s increased virulence and drug resistance.Keywords
All Related Versions
Funding Information
- Academy of Medical Sciences (SBF006\1090)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (306344/2021-1)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (307474/2020-8)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (310418/2016-0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (207422/2014-1)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (26/201.115/2022)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (26/204.546/2021)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (26/210.877/2019)
- Deutsches Zentrum für Infektionsforschung
This publication has 71 references indexed in Scilit:
- Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatmentClinical Microbiology and Infection, 2022
- CinA mediates multidrug tolerance in Mycobacterium tuberculosisNature Communications, 2022
- Type VII secretion systems: structure, functions and transport modelsNature Reviews Microbiology, 2021
- Population genomics provides insights into the evolution and adaptation to humans of the waterborne pathogen Mycobacterium kansasiiNature Communications, 2021
- CheckV assesses the quality and completeness of metagenome-assembled viral genomesNature Biotechnology, 2020
- High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundariesNature Communications, 2018
- Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecologyThe ISME Journal, 2014
- The biology of restriction and anti-restrictionCurrent Opinion in Microbiology, 2005
- Basic local alignment search toolJournal of Molecular Biology, 1990
- Phage typing of Mycobacterium kansasiiTubercle, 1980